Emitof-8 Tablet
Ondansetron 8 mg
Product Key Facts
Gastro-intestinal
Medications that support digestive health and help manage conditions like acid reflux, stomach ulcers, or constipation.
Digestive System Health
Digestive system medications, ranging from antacids and antiemetics to laxatives and probiotics, address conditions such as acid reflux, nausea, constipation, and bacterial infections. Professional guidance is essential for accurate diagnosis and proper use of these medications.
Details at a Glance
| Product Code | : | 1085 |
| Pack Size | : | 3x10's |
| MRP | : | ৳ 300 |
Specifications
Emitof-8 Tablet is categorized in the gastro-intestinal therapeutic class, serving as an antiemetic medication. Each tablet contains 8 mg of Ondansetron, a drug that falls under the class of serotonin 5-HT3 receptor antagonists. This medication is effective in preventing nausea and vomiting. It is available in packs containing 3 strips, each with 10 tablets, amounting to a total of 30 tablets per pack.
Emitof-8 Tablet, with its active ingredient Ondansetron 8 mg, is primarily indicated for the prevention and treatment of nausea and vomiting. This includes nausea and vomiting caused by chemotherapy, radiation therapy, and post-surgical procedures. Ondansetron works by blocking the actions of chemicals in the body that can trigger nausea and vomiting.
The dosage of Emitof-8 Tablet is determined based on the patient's medical condition and response to treatment. For adults undergoing chemotherapy or radiation therapy, the typical dose for preventing nausea and vomiting is 8 mg administered 30 minutes before the start of therapy, followed by subsequent doses as directed by a healthcare provider.
For the prevention of postoperative nausea and vomiting, the usual adult dose is 8 mg taken 1 hour before anesthesia. The tablet can be taken with or without food. If a dose is missed, it should be taken as soon as remembered, but if it's near the time for the next dose, the missed dose should be skipped, and the regular dosing schedule should continue. Avoid doubling the dose.
Patients should take Emitof-8 Tablet exactly as prescribed by their healthcare provider. While it is effective in managing nausea and vomiting, it might not completely eliminate these symptoms for every patient. It's important to inform the healthcare provider of all current medications to avoid potential interactions. Any side effects or unusual reactions experienced while taking Emitof-8 should be promptly communicated to a healthcare professional.
